Opticon Medical

Opticon Medical designs and develops innovative, cost-effective products for short-term urinary management and chronic urinary incontinence.
The Company has five FDA cleared products and a rich new product pipeline that positions the Company to address several important segments of the urinary management market.
Opticon's lead devices are the OPTION-vf® and OPTION-vm™ which have received FDA clearance. These products provide substantial benefits to patients, physicians and health care providers as they:

• Eliminate the tubes and collection bags that are required with Foley catheter systems

• Provide clinically proven, convenient and effective urinary management
• Mimic normal bladder functioning
• Provide greatly enhanced comfort and mobility
• Are less disruptive to normal daily activities
• Cause less self-consciousness and sleep disruption
• Are simple to use
• Have a combination of attributes that result in superior "quality of life" for patients